Physician profile
Ryan Patrick Shock
NPI 1952590754
$9,622.64
in general payments reported to CMS, 2019-2025
41 companies · $1,789 in 2025
The $1,789 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,571 · 2020: $208 · 2021: $538 · 2022: $391 · 2023: $2,540 · 2024: $2,585 · 2025: $1,789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,892 · Travel and Lodging: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,891.60 |
| Travel and Lodging | $1,022.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,305.96 | 2019-2025 | Augment Injectable, Actishield, Sonicanchor |
| Treace Medical Concepts, INC. | $2,243.87 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $586.41 | 2020-2025 | Nuzyra |
| Orthofix Medical, INC. | $542.62 | 2019-2025 | Physio-Stim, Spinal-Stim |
| Abbvie INC. | $499.69 | 2021-2025 | Dalvance |
| Smith+Nephew, INC. | $399.28 | 2019-2025 | Grafix, Versajet, Grafix Pl |
| Core Surgical Group | $294.01 | 2024-2025 | |
| Kerecis Limited | $291.89 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Osiris Therapeutics INC. | $282.48 | 2019 | |
| Convatec INC. | $228.43 | 2023-2024 | |
| Horizon Therapeutics Plc | $209.04 | 2019-2021 | |
| Abbott Laboratories | $208.44 | 2021-2024 | Proclaim |
| Bioventus LLC | $158.22 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $134.91 | 2023-2025 | Puraply, Via Matrix |
| Ermi LLC | $122.67 | 2019-2024 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $105.72 | 2019-2024 | Activbraid |
| Medtronic, INC. | $91.50 | 2023-2024 | Vanta Adaptivestim, Intellis Adaptivestim |
| Nevro Corp. | $77.23 | 2022-2024 | Senza |
| Integra Lifesciences Corporation | $76.69 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $61.60 | 2024 | |
| Grt US Holding, INC. | $59.20 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $56.44 | 2019-2022 | |
| Axogen | $52.03 | 2019 | |
| Osteocentric Technologies, INC. | $49.69 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Avanos Medical | $49.22 | 2021-2025 | On-Q Pump and Accessories |
| Pacira Pharmaceuticals Incorporated | $48.68 | 2023-2024 | Exparel, Iovera |
| Globus Medical, INC. | $47.54 | 2025 | Senza |
| Melinta Therapeutics, LLC | $46.99 | 2019 | |
| Osteomed LLC | $42.41 | 2019 | |
| Arteriocyte Medical Systems, INC. | $41.53 | 2019-2025 | Magellan |
| Mimedx Group, INC. | $31.57 | 2025 | |
| Baxter Healthcare | $28.60 | 2020 | |
| Averitas Pharma INC. | $24.99 | 2024 | Qutenza |
| Ossio INC | $23.81 | 2022 | |
| Anika Therapeutics, INC. | $16.59 | 2021 | |
| Amgen INC. | $15.54 | 2024 | Krystexxa |
| Heron Therapeutics, INC. | $14.64 | 2021 | |
| Paragon 28, INC. | $14.63 | 2021 | |
| Cpm Medical Consultants, LLC | $13.79 | 2020 | |
| Merck Sharp & Dohme LLC | $12.15 | 2019 | |
| Nabriva Therapeutics, Plc | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Shock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.